Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1

被引:2
|
作者
Li, Mao [1 ]
Wang, Zhanjun [2 ]
Cui, Fang [1 ]
Yang, Fei [1 ]
Wang, Hongfen [1 ]
Huang, Xusheng [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2020年 / 11卷
基金
中国国家自然科学基金;
关键词
myotonic dystrophy type 1; MIRS; multisystemic impairment; cataract; hypogonadism; cardiac abnormalities; QUALITY-OF-LIFE; CTG REPEAT; INVOLVEMENT; PREVALENCE; DISABILITY; FEATURES; COHORT; DEATH; AGE;
D O I
10.3389/fneur.2020.00277
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disease characterized by muscle weakness and multisystemic impairments, which significantly impact the quality of life. There is currently an increasing consensus on the necessity of a multidisciplinary assessment in patients with DM1, to improve the management of the disease. Methods: To analyze the prevalence and pairwise relationships between various organs involved, we performed a retrospective study by reviewing demographic and clinical information of DM1 patients including age, disease duration, clinical history, muscular impairment rating scale score (MIRS), results of blood biochemistry, electrocardiogram, echocardiography, and ophthalmologic examination. Results: Ninety three DM1 patients (60 males and 33 females), aged 34.7 +/- 12.6 (mean +/- standard deviation) years were recruited. Of which, two congenital cases were of maternal and paternal inheritance, respectively. In the other 91 patients, cataract was found in 44.1% of patients, followed by hypogonadism (40.8%), frontal balding (40.7%), and cardiac abnormalities (34.5%). Thyroid dysfunction and insulin insensitivity were relatively uncommon. Age (p < 0.001) is independently correlated with cataract, and MIRS correlates positively with cardiac abnormalities (p = 0.005) and frontal balding (p = 0.015). Male patients more frequently had frontal balding (Risk ratio, 3.98; 95% confidence interval, 1.493-10.611) compared with female patients. Male patients with cataract presented more frequent cardiac abnormalities (Risk ratio, 4.40; 95% confidence interval, 1.055-18.358) compared with non-cataract male patients. Hypogonadism in male patients was characterized as decreased testosterone level, accompanied by elevated levels of luteinizing hormone and follicle-stimulating hormone. Conclusions: In Chinese patients with DM1, we conclude that (1) cataract, hypogonadism, frontal balding and cardiac abnormalities are frequently observed; (2) age is an independent indicator to cataract and MIRS is the only predictor for cardiac abnormalities and frontal balding; (3) a positive correlation between ophthalmologic and cardiac impairments in male patients is found; (4) endocrine abnormalities show diverse manifestations and hormone tests are recommended; (5) particular attention should be given to patients with older age and higher MIRS score.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Endocrine function in 97 patients with myotonic dystrophy type 1
    Orngreen, M. C.
    Arlien-Soborg, P.
    Duno, M.
    Hertz, J. M.
    Vissing, J.
    JOURNAL OF NEUROLOGY, 2012, 259 (05) : 912 - 920
  • [22] MYOTONIC DYSTROPHY TYPE 1 OR STEINERT'S DISEASE
    Romeo, Vincenzo
    NEURODEGENERATIVE DISEASES, 2012, 724 : 239 - 257
  • [23] Myotonic dystrophy type 1: frequency of ophthalmologic findings
    Ikeda, Karin Suzete
    Iwabe-Marchese, Cristina
    Franca, Marcondes Cavalcante, Jr.
    Nucci, Anamarli
    de Carvalho, Keila Monteiro
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (03) : 183 - 188
  • [24] TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
    Bose, Francesca
    Renna, Laura Valentina
    Fossati, Barbara
    Arpa, Giovanni
    Labate, Valentina
    Milani, Valentina
    Botta, Annalisa
    Micaglio, Emanuele
    Meola, Giovanni
    Cardani, Rosanna
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [25] Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1
    Fujino, Haruo
    Saito, Toshio
    Takahashi, Masanori P.
    Takada, Hiroto
    Nakayama, Takahiro
    Imura, Osamu
    Matsumura, Tsuyoshi
    BMC NEUROLOGY, 2022, 22 (01)
  • [26] Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
    Ali, Marco
    Monti, Caterina Beatrice
    Melazzini, Luca
    Cardani, Rosanna
    Fossati, Barbara
    Cavalli, Michele
    Chow, Kelvin
    Secchi, Francesco
    Meola, Giovanni
    Sardanelli, Francesco
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [27] Orthopaedic Disorders in Myotonic Dystrophy Type 1: descriptive clinical study of 21 patients
    Schilling, Lisa
    Forst, Raimund
    Forst, Juergen
    Fujak, Albert
    BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [28] Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1
    Kersten, Hannah M.
    Roxburgh, Richard H.
    Child, Nicholas
    Polkinghorne, Philip J.
    Frampton, Chris
    Danesh-Meyer, Helen V.
    JOURNAL OF NEUROLOGY, 2014, 261 (01) : 37 - 44
  • [29] Clinical, Psychosocial, and Central Correlates of Quality of Life in Myotonic Dystrophy Type 1 Patients
    Laberge, Luc
    Mathieu, Jean
    Auclair, Julie
    Gagnon, Eric
    Noreau, Luc
    Gagnon, Cynthia
    EUROPEAN NEUROLOGY, 2013, 70 (5-6) : 308 - 315
  • [30] A genetic systemic disease: Clinical description of type 1 myotonic dystrophy in adults
    Kaminsky, P.
    Pruna, L.
    REVUE DE MEDECINE INTERNE, 2012, 33 (09): : 514 - 518